Filters

Jak1 (Tyr1034 + Tyr1035) Antibody

Jak1 (Tyr1034 + Tyr1035) Antibody size: 0.1ml 281

Supplier BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price 281
Size 0.1ml
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long nameJak1 (Tyr1034 + Tyr1035) Antibody
Also known asJak1 (Tyr1034 + Tyr1035) Antibody
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenJak1 Tyr1034 + Tyr1035
SpecificityThis is a highly specific antibody against Jak1 Tyr1034 + Tyr1035
Modification(s)Phosphorylation
Modification site(s)Tyr1034 + Tyr1035
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
SourceKLH conjugated synthetic phosphopeptide derived from human Jak1 around the phosphorylation site of Tyr1034 + Tyr1035
Gene ID number3716
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen Kinase partner for the interleukin (IL)-2 receptor, involved in the IFN-alpha/beta/gamma signal pathway, Tyrosine kinase of the non-receptor type
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names JAK-1, JAK1, JAK1A, JAK1B, Janus kinase 1, Tyrosine-protein kinase JAK1
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetJak1 (Tyr1034 + Tyr1035)
Short nameJak1 (Tyr1034 + Tyr1035) Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameJanus kinase 1 (Tyr1034 and Tyr1035) (Antibody to)
Alternative techniqueantibodies

Similar products

Subscribe to our Newsletter